Analysts See $-0.95 EPS for Catabasis Pharmaceuticals, Inc. (CATB) | Thorold News - Thorold News

Analysts See $-0.95 EPS for Catabasis Pharmaceuticals, Inc. (CATB) | Thorold News  Thorold News

Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.95 EPS on March, 21.They anticipate $1.45 EPS change or 60.42 % from last ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today